Trifluoromethanesulfonic Acid

Trifluoromethanesulfonic Acid

SCHEMBL7090348

O=S(=O)(O)C(F)(F)F.O=S(=O)(O)C(F)(F)F.O=S(=O)(O)C(F)(F)F.O=S(=O)(O)C(F)(F)F.O=S(=O)(O)C(F)(F)F.O=S(=O)(O)C(F)(F)F.[Al+3].[O-]c1cc(F)cc(F)c1.[O-]c1cc(F)cc(F)c1.[O-]c1cc(F)cc(F)c1

nearest known ligand 0.34

Full drug profile on Sugi Atlas →

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 1/20 0.34
CES2 O00748 1/20 0.33
CES1 P23141 1/20 0.33
CA12 O43570 1/20 0.32
CA1 P00915 1/20 0.32
CA9 Q16790 1/20 0.32
VEGFA P15692 1/20 0.31
SOS1 Q07889 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoromethanesulfonic Acid SCHEMBL7090349 0.85 GPR3 (0.41) PTPN1CES2CES1SOS1
Trifluoromethanesulfonic Acid SCHEMBL7089262 0.81 PTPN1 (0.47) PTPN1CES2CES1CA12CA1
Trifluoromethanesulfonic Acid SCHEMBL28703240 0.78 CA12 (0.59) PTPN1CES2CES1CA12CA1
Trifluoromethanesulfonic Acid SCHEMBL27873140 0.77 PTPN1 (0.35) PTPN1CES2CES1CA12CA1
Trifluoromethanesulfonic Acid SCHEMBL7089707 0.75 GABRA1 (0.39) PTPN1
Trifluoromethanesulfonic Acid SCHEMBL7489155 0.75 CYP19A1 (0.39) CA1CA9
Trifluoromethanesulfonic Acid SCHEMBL7089666 0.73 ALDH1A1 (0.39) CA1
Trifluoromethanesulfonic Acid SCHEMBL7655778 0.72 GPR3 (0.41) PTPN1CES1CA1CA9
Trifluoromethanesulfonic Acid SCHEMBL7089460 0.71 CA1 (0.33) CA1
SCHEMBL3874006 0.71 PTPN1 (0.53) PTPN1CES2CES1CA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6624321-B2 Metathesis ring-opening polymerization of cyclic ethers in the presence of catalysts such as aluminum bis(trifluoromethane-sulfonate) phenolate BAYER AKTIENGESELLSCHAFT (DE) 2003-09-23 US disclosed
US-20030097026-A1 Process for the preparation of polyether polyols DENNINGER UWE (DE) 2003-05-22 US disclosed
US-6492565-B2 USING ALKYLENE OXIDE IN PRESENCE OF LEWIS ACID CATALYST BAYER AKTIENGESELLSCHAFT (DE) 2002-12-10 US disclosed
US-20010053866-A1 Process for the preparation of polyether polyols BAYER AKTIENGESELLSCHAFT (DE) 2001-12-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030097026-A1 Process for the preparation of polyether polyols PCBP1, FHIT, PUF60 PTPN1 3839/4885CES2 826/4885CES1 1554/4885
US-20010053866-A1 Process for the preparation of polyether polyols PCBP1, FHIT, PUF60 PTPN1 3839/4885CES2 826/4885CES1 1554/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.